November 15, 2019 / 12:42 PM / 20 days ago

BRIEF-Promedior Says To Be Acquired By Roche

Nov 15 (Reuters) - Promedior:

* PROMEDIOR ENTERS INTO DEFINITIVE MERGER AGREEMENT TO BE ACQUIRED BY ROCHE

* PROMEDIOR - TOTAL TRANSACTION VALUE OF UP TO $1.39 BILLION

* PROMEDIOR - UNDER TERMS OF MERGER AGREEMENT, ROCHE WILL MAKE UPFRONT CASH PAYMENT OF USD 390 MILLION

* PROMEDIOR - ROCHE WILL OBTAIN RIGHTS TO PROMEDIOR’S ENTIRE PORTFOLIO OF MOLECULES FOR SERIOUS FIBROTIC DISEASES, NOTABLY PRM-151

* PROMEDIOR - DEAL CONSIDERATION ALSO HAS ADDITIONAL CONTINGENT PAYMENTS OF UP TO $1 BILLION BASED ON ACHIEVEMENT OF CERTAIN MILESTONES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below